- QMRO Home
- William Harvey Research Institute
- Centre for Microvascular Research (CMR)
- Antibody-mediated inhibition of syndecan-4 dimerisation reduces interleukin (IL)-1 receptor trafficking and signalling.
Browse
Administrators only